Replies to post #53499 on Biotech Values

[rfj1862]

>Where do you see RPRX ending the day tomorrow (Tue)?<

You didn't ask me, but RPRX should go up nearly the equivalent of what it would if positive results from a pivotal phase III trial were announced. Positive endocrine results for future trials of Androxal are nearly 100% certain.

It's not going to happen, of course. There seems to be a fundamental misunderstanding of this company and its products.

[spartex]

Dew, imo I would anticipate a 3/4 to 1 dollar move up in the stock tomorrow. With further gains once the story is better understood by the greater wall street mor"asses".

I continue to see only positive news and results come out of this company the past 11 months. A rare feat for any biotech imho!

[ThomasS]

I'm absolutely clueless on that question.
The bigger question for me remains the same: market cap 12 months from now...

[croumagnon]

"Where do you see RPRX ending the day tomorrow"

I'll take a stab at that. There will be no retail sellers or institutional sellers tomorrow, and the only possible sellers will be shorts trying to stem any momemtum. On the other hand, buyers will be timid to chase the stock because of the fear of a delay by an additional phase II trial to determine the required endocrine endpoints...

I plan to be a buyer all the way to $12 and I do not plan to sell any before $15. My thinking is that the stock will end the day tomorrow somewhere in the $13's but it may start the day at much more modest levels. One month from now I see RPRX trading north of $15...